drugset / Trial / NCT06558006
Safety and Efficacy Predimenol for Headache
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a prospective, double-blind, placebo-controlled and randomized study aimed to obtain a description of the efficacy and safety of Predimenol in alleviating headache.
Timeline
- Start
- 2024-06-19
- Primary completion
- 2024-10-15
- Completion
- 2024-10-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Predimenol | Unknown | 200 mg | Oral |
| Subject | Predimenol | Unknown | 400 mg | Oral |